The second batch of two science and technology major projects reviewed

Recently, the reporter learned from the Science and Technology Management Office of the State Food and Drug Administration that at present, all the evaluations of the second batch of major scientific and technological projects of “Major New Drug Creation” and “Control of Major Infectious Diseases such as AIDS and Viral Hepatitis” have been completed and submitted for approval. stage. There are 12 topics in the two special projects led by the direct units of the National Bureau.

Among the topics completed by the review, the topic of “Biotechnology Drug Quality Standards and Quality Control Technology Platform” was led by the China Inspection Institute; the “Innovative Drug Technology Evaluation Support and Service Platform” in the “New Drug R&D Information Technology Platform” was initiated by the Drug Testing Center. Leading the project of “establishing a new drug development safety monitoring information technology platform” is led by the certification center; the “Chinese medicine quality standard research and information system construction platform” in the “Chinese medicine standard research platform” is led by the Pharmacopoeia, “Dangerous residues in Chinese medicine” The "Technical Standard Platform for Physical Testing" and the "Technology Platform Construction for the Development and Development of Standard Substances for Traditional Chinese Medicine" are led by the Central Inspection Institute; "Research on AIDS Vaccine Evaluation Technology" in "Infectious Disease Prevention and Control Related Product Evaluation Technology Platform", "B Research on Quality Control and Evaluation of Hepatitis B Vaccine, "Quality Control and Evaluation of Tuberculosis Prevention Related Products", "Research on Vaccine Quality Control Technology and Standardization" and "Comprehensive Technology Platform for Quality Evaluation of Major Infectious Disease Diagnostic Products" Take the lead. In addition, in the special* batch project, the “Drug Safety Evaluation Technology Platform” led by the China Inspection Institute has also passed the expert review.

The development of these 12 research projects will promote the establishment of drug quality control technology platform, innovative drug technology evaluation support and service platform, new drug research and development safety monitoring information technology platform, and promote the improvement of China's drug technology supervision capability and drug regulatory technology system. perfect.

The main ingredients include: rose oil, deionized water, hyaluronic acid, citric acid, ethanol, glycerol. Product Benefits: Deeply moisturizes and rough skin, softens the cuticle, helps the aged dead skin to fall off Effectively improves the appearance of dry, rough skin on the feet, leaving the feet clean and fresh, healthy and energetic.

Structure and composition]
Exfoliating foot membrane mainly by the essence of fluid, the composition of the foot protection film.
The main components
Rose oil, deionized water, hyaluronic acid, citric acid, ethanol, glycerol.
[Benefits]
Deep moisturizing and dry rough skin, soften the cuticle, to help the aging dead skin shedding effectively improve the foot skin dry, rough and so on,
Make feet more clean and fresh, healthy and energetic.
[Instructions]
1, before use, wash your feet dry;
2, the Siamese foot set cut along the middle of the set, will be fitted with the essence of the full set of foot membrane worn on the foot;
3, wear 20-30 minutes after removing the foot membrane cover; wash with water can be (do not use hand wash);

Beauty Foot Mask

Beauty Foot Mask,Peeling Foot Mask,Beauty Exfoliating Foot Mask,Foot Mask For Foot Care

Hebei Houde Hanfang Medical Devices Co., LTD. , https://www.hodafhealth.com